Abilify Maintena and Vitrakvi (Larotrectinib Capsules)
Determining the interaction of Abilify Maintena and Vitrakvi (Larotrectinib Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify Maintena, Aristada, Abilify, Abilify Discmelt, Abilify MyCite, Aristada Initio
Synonyms: Abilify Maintena (injection)
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abilify Maintena-Vitrakvi (Larotrectinib Oral Solution)
- Abilify Maintena-Vitrase
- Abilify Maintena-Vitrase injection
- Abilify Maintena-Vitravene
- Abilify Maintena-Vitron-C
- Abilify Maintena-Vituz
- Vitrakvi (Larotrectinib Capsules)-Abilify Maintena injection
- Vitrakvi (Larotrectinib Capsules)-Abilify MyCite
- Vitrakvi (Larotrectinib Capsules)-Abiraterone
- Vitrakvi (Larotrectinib Capsules)-Abiraterone acetate
- Vitrakvi (Larotrectinib Capsules)-Abiraterone Acetate (Yonsa)
- Vitrakvi (Larotrectinib Capsules)-Abiraterone Acetate (Zytiga)